Assessment of patient-reported outcomes for patients with ankylosing spondylitis treated with etanercept for up to 160 weeks.

被引：0
|
作者：
Dijkmans, Benjamin A. C.
Sieper, Joachim
van der Linden, Sjef
Sibilia, Jean
Mola, Emilio Martin
Leirisalo-Repo, Marjatta
Pedersen, Ronald
Singh, Amitabh
Freundlich, Bruce
MacPeek, David
机构：
[1] Vrije Univ Amsterdam, AZ, Amsterdam, Netherlands
[2] Med Klin 1 Rheumatol, Berlin, Germany
[3] Univ Maastricht, Maastricht, Netherlands
[4] Hop Hautepierre, Strasbourg, France
[5] Hosp La Paz, Madrid, Spain
[6] Wyeth Res, Collegeville, PA USA
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S725 / S725
页数：1
相关论文
共 50 条
  • [1] Patient reported outcomes of improvement in patients with ankylosing spondylitis treated iwth etanercept for 148 to 160 weeks
    Dijkmans, B. A. C.
    Sieper, J.
    Van der Linden, S.
    Sibilia, J.
    Mola, E. Martin
    Leirisalo-Repo, M.
    Pedersen, R.
    Singh, A.
    Freundlich, B.
    MacPeek, D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 432 - 432
  • [2] Significant improvement in patient-reported outcomes for patients with ankylosing spondylitis treated with etanercept
    Singh, A.
    McHugh, N.
    Wajdula, J. S.
    Paolozzi, L.
    Zang, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 602 - 602
  • [3] Assessment of patient-reported outcomes from a randomized, DoubleBlind study of etanercept and Sulphasalazine in patients with Ankylosing spondylitis
    Sieper, J.
    Moots, R.
    Taylor, A.
    Sato, R.
    Singh, A.
    Robertson, D.
    Freundlich, B.
    Koenig, A. S.
    Vlahos, B.
    Ganguly, R.
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S580 - S581
  • [4] The effects of etanercept on patient-reported outcomes for subjects with ankylosing spondylitis.
    van der Heijde, D
    Dougados, M
    Davis, JC
    Woolley, JM
    Tsuji, W
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S174 - S175
  • [5] Improvements in patient-reported outcomes for subjects with ankylosing spondylitis receiving etanercept therapy
    Davis, JC
    Woolley, JM
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 252 - 252
  • [6] Five-year efficacy and safety, including patient-reported outcomes, with etanercept in ankylosing spondylitis
    Mola, E. Martin
    van der Linden, S.
    Wishneski, C.
    Robertson, D.
    Freundlich, B. F.
    Koenig, A. S.
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S584 - S585
  • [7] Sustained efficacy and safety of patients with ankylosing spondylitis treated with etanercept: Outcomes at 148-160 weeks of long term therapy.
    Sieper, Joachim
    Dijkmans, Benjamin A. C.
    van der Linden, Sjef
    Mola, Emilio Martin
    Sibilia, Jean
    Leirisalo-Repo, Majatta
    Nab, Henk W.
    Chang, David
    Freundlich, Bruce
    MacPeek, David
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S473 - S473
  • [8] Sustained efficacy and safety, including patient-reported outcomes, with etanercept treatment over 5 years in patients with ankylosing spondylitis
    Martin-Mola, E.
    Sieper, J.
    Leirisalo-Repo, M.
    Dijkmans, B. A. C.
    Vlahos, B.
    Pedersen, R.
    Koenig, A. S.
    Freundlich, B.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : 238 - 245
  • [9] Association of Healthcare Utilization and Costs with Patient-Reported Outcomes in Patients with Ankylosing Spondylitis
    Ogdie, Alexis
    Hwang, Mark
    Veeranki, Phani
    Portelli, Alexandria
    Sison, Steven
    Shafrin, Jason
    Pedro, Sofia
    Yi, Esther
    Michaud, Kaleb
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [10] Long term efficacy and safety results and patient reported outcomes in patients with ankylosing spondylitis treated with etanercept for 4 years
    Dijkmans, B. A. C.
    Sieper, J.
    van der Linden, S.
    Martin-Mola, E.
    Leirisalo-Repo, M.
    Singh, A.
    Freundlich, B.
    Koenig, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 395 - 395
12345